Handok Inc.: Diabetes Mellitus, Type 2 trials

The registry lists 13 Diabetes Mellitus, Type 2 studies with Handok Inc. as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 3 5Phase 4 6No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and MetforminCompletedNCT05504239Phase 3
• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and MetforminCompletedNCT05504226Phase 3
• Pharmacokinetic Drug Interaction Between Teneligliptin and EmpagliflozinCompletedNCT04431141Phase 1
• Observational Study to Evaluate the Efficacy and Safety of TeneligliptinCompletedNCT03793023
• Tenelia Elderly CGMS Study(TEDDY)CompletedNCT03508323Phase 4
• Tenelia Triple Combination StudyCompletedNCT02567994Phase 3
• Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)CompletedNCT02512523Phase 4
• Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes MellitusCompletedNCT01798238Phase 3
• Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
• Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00975065Phase 4
• Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes MellitusCompletedNCT00913367Phase 4
• Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DMCompletedNCT00612144Phase 4
• Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)CompletedNCT00437554Phase 3